← Leaderboards
Kelsey Wanhainen
University Of Minnesota
$160,826
Attributed
$160,826
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $46.1K · FY2020–23$50K$37.5K$25K$12.5K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$160,826 · 1
By mechanism
F30$160,826 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota
Same institution · by research overlap
- Bruce R. Blazar$144,460,093
- Randolph J. Noelle$36,126,144
- John E Wagner$7,593,142
- David Masopust$22,435,964
- Ingunn Margarete Stromnes$4,130,375
Others in their field
Other Emerging Leaders on “Adenosine Triphosphate”
- Wei Lu · Van Andel Research Institute$4,058,147
- Paolo Cassano · New York University School Of Medicine$3,422,329
- Elizabeth Rendina-Ruedy · Mainehealth$3,146,969
- Daniel Botelho Costa · Beth Israel Deaconess Medical Center$2,380,664
- Heather Wendy Pinkett · Northwestern University$2,271,138
- Rebecca Diane Levit · Emory University$2,228,802
Research focus
Adenosine TriphosphateAblationAerobic GlycolysisAgonistAdoptive Cell TransfersAnti-Tumor Immune ResponseAntitumor ResponseCancer ControlCancer TherapyCareerCd8-Positive T-LymphocytesCell DeathCell InjuryCell MaintenanceCell PhysiologyCellsCell SurvivalCellular ImmunotherapyCellular StressCessation Of LifeChronicClinicCytokineEffector T Cell
Grant awards (4)
Role of P2RX7 in making CD8+ T cells for tumor immunotherapy.$46,127
F30 · FY2023 · CA · contact PI
Role of P2RX7 in making CD8+ T cells for tumor immunotherapy.$34,014
F30 · FY2022 · CA · contact PI
Role of P2RX7 in making CD8+ T cells for tumor immunotherapy.$40,739
F30 · FY2021 · CA · contact PI
Role of P2RX7 in making CD8+ T cells for tumor immunotherapy.$39,946
F30 · FY2020 · CA · contact PI